Before We Start
Same organism, three completely different diseases
It's tempting to think one organism causes one disease. Aspergillus breaks that assumption cleanly — the same mold produces an allergic reaction, a colonizing fungus ball, or a life-threatening invasive infection, purely depending on who's being infected.
💡 Memory Trick
Aspergillus: "Septate hyphae at 45°." Invasive in neutropenic. Aspergilloma = fungus ball in old TB cavities. The host determines the disease — asthma/CF gets ABPA, an old cavity gets a fungus ball, neutropenia gets a true emergency.
The Key Points
One organism, three hosts, three genuinely different diseases
Asp
Aspergillus fumigatus — a ubiquitous mold
Aspergillus fumigatus is found virtually everywhere in the environment. On microscopy, it shows septate hyphae branching at 45-degree angles — a distinguishing feature from other molds. What disease it causes depends entirely on the host, not the organism itself, since the same mold produces three completely different presentations.
🦠 The 45-degree branching angle on microscopy is a specific visual identifier that distinguishes Aspergillus from other molds with different branching patterns.
ABPA
Allergic bronchopulmonary aspergillosis — an allergic reaction, not an infection
In patients with asthma or cystic fibrosis, inhaled Aspergillus spores don't invade tissue at all — instead they trigger an IgE-mediated allergic reaction in the airways, worsening asthma control and causing characteristic mucus plugging, without the fungus actually growing into lung tissue.
🦠 A patient with poorly controlled asthma and worsening mucus plugging, without any evidence of tissue invasion on imaging, reflects ABPA's purely allergic mechanism rather than a true infection.
Ball
Aspergilloma — colonizing an old cavity without truly invading
In a patient with a pre-existing lung cavity — most classically from prior tuberculosis, but also sarcoidosis — Aspergillus can colonize that empty space and grow into a visible "fungus ball" without truly invading the surrounding tissue at all, making it a fundamentally less urgent situation than invasive disease.
🦠 A patient with an old, healed TB cavity developing a visible fungus ball on imaging, without fever or systemic illness, reflects colonization of dead space rather than active tissue invasion.
Inv
Invasive aspergillosis — the life-threatening form
In neutropenic patients — classically those with AML undergoing chemotherapy, or transplant recipients — Aspergillus becomes genuinely invasive, growing directly into blood vessels (angioinvasion) and causing hemorrhagic tissue infarcts. The classic imaging finding is the halo sign on CT chest. First-line treatment is voriconazole, with amphotericin B as an alternative.
🦠 A patient undergoing induction chemotherapy for AML becomes neutropenic and develops a fever; CT chest shows a halo sign — this is invasive aspergillosis, requiring urgent voriconazole treatment given the angioinvasive, life-threatening nature of the disease in this specific host.
🏥 Applied Scenario
A patient with AML is undergoing chemotherapy and becomes severely neutropenic, then develops fever with a CT chest showing a halo sign around a lung nodule.
Step 1
Identify which presentation this matches: Which of the three Aspergillus presentations does this match? The neutropenic host and halo sign point specifically to invasive aspergillosis — a life-threatening, angioinvasive disease requiring urgent antifungal treatment (voriconazole first-line).
Step 2
Contrast with a different host presenting the same finding: If this same CT finding appeared in a patient with a history of tuberculosis and an old lung cavity, but no neutropenia, the presentation would instead be aspergilloma — colonization without true tissue invasion, a fundamentally less urgent situation.
Step 3
Recognize why host status changes everything: The exact same organism, and even a similar-looking imaging finding, can represent a true emergency or a stable chronic finding depending entirely on the patient's immune status.
Step 4
Conclusion: Before deciding how urgently to act on an Aspergillus finding, the host's immune status — not just the imaging or the organism — is the deciding factor.
📌 Exam Application
Exams test matching each Aspergillus presentation to its host: ABPA in asthma/CF patients (allergic, IgE-mediated), aspergilloma in patients with pre-existing cavities like old TB (colonization, not invasion), and invasive aspergillosis in neutropenic patients (angioinvasive, halo sign, voriconazole treatment).
⚠️ The Trap — Treating All Three Presentations as Equally Urgent
The most common trap is treating all three presentations as equally urgent or as the same disease process. Aspergilloma is essentially colonization of dead space and often doesn't require aggressive systemic antifungal therapy, while invasive aspergillosis is a true emergency requiring immediate treatment — confusing the two could mean under-treating a life-threatening infection or over-treating a stable colonization.
✓ Quick Self-Test
Answer before checking:
1. What does Aspergillus look like on microscopy?
2. What triggers ABPA, and in which patients does it occur?
3. What is an aspergilloma, and where does it typically form?
4. What patient population is at risk for invasive aspergillosis, and what is the classic CT finding?
5. What is the first-line treatment for invasive aspergillosis?
Answers:
1. Septate hyphae branching at 45-degree angles.
2. An IgE-mediated allergic reaction to inhaled Aspergillus spores, occurring in patients with asthma or cystic fibrosis.
3. A fungus ball that colonizes a pre-existing lung cavity, most classically from prior tuberculosis.
4. Neutropenic patients (AML, transplant recipients); the classic finding is the halo sign.
5. Voriconazole, with amphotericin B as an alternative.